Literature DB >> 22918715

Clinical applications of the latest molecular diagnostics in noninvasive prenatal diagnosis.

K C Allen Chan1.   

Abstract

The presence of cell-free fetal DNA in the plasma of pregnant women has opened up the possibility of noninvasive prenatal diagnosis. With the advances in molecular techniques of microfluidics and massive parallel sequencing, an increasing number of fetal genetic diseases/conditions can be noninvasively detected using maternal plasma DNA analysis. Remarkably, it has recently been shown that the genome-wide genetic map of an unborn fetus can be constructed through extensive sequencing of maternal plasma DNA. In this chapter the different qualitative and quantitative approaches and related methodology for the analysis of fetal DNA in maternal plasma are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 22918715     DOI: 10.1007/128_2012_352

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN: 0340-1022


  2 in total

Review 1.  Nanostructures in non-invasive prenatal genetic screening.

Authors:  Samira Sadeghi; Mahdi Rahaie; Bita Ostad-Hasanzadeh
Journal:  Biomed Eng Lett       Date:  2021-10-11

2.  Impact of Cell-Free Fetal DNA Screening on Patients' Choice of Invasive Procedures after a Positive California Prenatal Screen Result.

Authors:  Forum T Shah; Kathryn Steinhaus French; Kathryn E Osann; Maureen Bocian; Marilyn C Jones; Lauren Korty
Journal:  J Clin Med       Date:  2014-07-24       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.